PRIME
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Mar 2023)
What this means for you
This application is over — abandoned 20 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88856485
- Mark type
- Stylized text
- Filed
- 01 Apr 2020
- Published for opposition
- 23 Feb 2021
- Abandoned
- 20 Mar 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and therapeutic vaccines, namely, cellular preparations, T-cell preparations and DC (dendritic cell) for the treatment of cancer, immune system related diseases, and infectious disease
Owner
- Repertoire Immune Medicines, Inc., Cambridge, MA, US
- Repertoire Immune Medicines, Inc., Cambridge, MA, US
Prosecution history
- 20 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2022 — SOU EXTENSION 2 GRANTED
- 15 Aug 2022 — SOU EXTENSION 2 FILED
- 15 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2022 — SOU EXTENSION 1 GRANTED
- 14 Feb 2022 — SOU EXTENSION 1 FILED
- 14 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 17 Aug 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Jul 2021 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 22 Mar 2021 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 23 Feb 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Feb 2021 — PUBLISHED FOR OPPOSITION